Calian Group (CGY) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
2 Apr, 2026Business overview and market position
Over 40 years in operation with a workforce of 5,800 and a market cap of $542M.
FY24 revenues reached $747M, with 49% from commercial and 51% from government customers.
Revenue segmentation: 29% ITCS, 28% Advanced Technologies, 28% Health, 15% Learning.
68% of revenues are Canadian, 32% international; 70% services, 30% products.
Key customers span defence, space, health, and government sectors.
Industry tailwinds and growth drivers
Defence, space, and health sectors are experiencing strong growth due to increased spending and technological advancements.
Defence revenues have grown at a 14% CAGR, reaching $363M in LTM Q2-25.
Defence exposure: 49% of FY24 revenues, with significant contributions from health and learning segments.
Global trends include increased defence budgets, aging populations, and focus on preventive healthcare.
Financial performance and execution
Double-digit revenue (15% CAGR) and adjusted EBITDA (21% CAGR) growth from 2017 to 2024.
Strategic plan targets $1B in revenues and $125M in adjusted EBITDA by FY26, driven by organic and acquisition growth.
Recent acquisitions (e.g., AMS, Mabway) have expanded offerings and geographic reach.
Short-term headwinds in ITCS due to cost pressures and delayed procurement decisions.
Latest events from Calian Group
- Record Q1 revenue and EBITDA growth, driven by Defence & Space and acquisitions, support strong outlook.CGY
Q1 202616 Apr 2026 - Defence revenues hit $373M with a $1B backlog, driven by new contracts and acquisitions.CGY
Investor presentation2 Apr 2026 - Double-digit growth, strong cash flow, and acquisitions drive expansion and shareholder value.CGY
Investor presentation2 Apr 2026 - Defence revenues hit $330M in FY24, driven by global expansion and portfolio strength.CGY
Investor presentation2 Apr 2026 - On track for $1B revenue by FY26, fueled by strong growth, M&A, and diversified segments.CGY
Investor presentation2 Apr 2026 - On track for $1B revenue by FY26, with robust growth, strong M&A, and raised FY24 EBITDA guidance.CGY
Investor presentation2 Apr 2026 - On track for $1B revenue by FY26, with strong growth, margins, and M&A execution.CGY
Investor presentation2 Apr 2026 - Double-digit growth, strong cash flow, and disciplined acquisitions drive rising shareholder value.CGY
Investor presentation2 Apr 2026 - Defence, space, and health growth drive record revenues, EBITDA, and shareholder value.CGY
Investor presentation2 Apr 2026